Mitsubishi UFJ Asset Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-37,154
| Closed | -$168K | – | 1572 |
|
|
2024
Q1 | $168K | Sell |
37,154
-1,701
| -4% | -$7.71K | ﹤0.01% | 974 |
|
|
2023
Q4 | $221K | Buy |
38,855
+4,641
| +14% | +$26.5K | ﹤0.01% | 997 |
|
|
2023
Q3 | $157K | Hold |
34,214
| – | – | ﹤0.01% | 1044 |
|
|
2023
Q2 | $221K | Buy |
34,214
+19,083
| +126% | +$123K | ﹤0.01% | 1024 |
|
|
2023
Q1 | $114K | Buy |
15,131
+2,140
| +16% | +$16.1K | ﹤0.01% | 1081 |
|
|
2022
Q4 | $123K | Sell |
12,991
-8,875
| -41% | -$84.2K | ﹤0.01% | 1073 |
|
|
2022
Q3 | $216K | Buy |
21,866
+9
| +0% | +$89 | ﹤0.01% | 1014 |
|
|
2022
Q2 | $233K | Buy |
21,857
+5,849
| +37% | +$62.4K | ﹤0.01% | 1027 |
|
|
2022
Q1 | $156K | Buy |
16,008
+1,854
| +13% | +$18.1K | ﹤0.01% | 1089 |
|
|
2021
Q4 | $200K | Buy |
14,154
+7,096
| +101% | +$100K | ﹤0.01% | 1084 |
|
|
2021
Q3 | $141K | Hold |
7,058
| – | – | ﹤0.01% | 1092 |
|
|
2021
Q2 | $155K | Buy |
+7,058
| New | +$155K | ﹤0.01% | 1104 |
|